Actualités de SWITZERLAND
- plus
Tetra Pak Achieves 50% Renewable Electricity Consumption in Just Two Years Since RE100 Commitment
Lausanne, Switzerland (ots/PRNewswire) - Tetra Pak now obtains half of its global electricity supply from renewable sources, putting the company firmly on course to meet its RE100 commitment of using only renewable electricity across all global operations by 2030. (Logo: https://mma.prnewswire.com/media/632361/Tetra_Pak_Logo.jpg ) (Photo: ...
plusTetra Pak Index 2018 Says Smart Packaging Offers Exciting Opportunities in Fast Growing Online Grocery
Lausanne, Switzerland (ots/PRNewswire) - Smart packaging technologies based on unique digital codes will take both online and off-line grocery in exciting new directions during the next few years, says the Tetra Pak Index 2018, launched today. (Logo: https://mma.prnewswire.com/media/632361/Tetra_Pak_Logo.jpg ) ...
plus- 2
icotec AG Received FDA Clearance to Market BlackArmor® Carbon/PEEK Interbody Cages
plus Hitachi Medical Systems Europe Holding AG
Hitachi Medical Systems Europe wins the contract to supply 6 ultrasound systems in the UK helping to improve prostate cancer diagnosis ...
Zug, Switzerland (ots) - Hitachi Medical Systems Europe wins the contract to supply 6 ultrasound systems in the UK helping to improve prostate cancer diagnosis as part of the innovative RAPID programme at three major hospitals across South West London The new RAPID (Rapid Assessment Prostate Imaging and Diagnosis) ...
plusGalderma Global Study Reveals True Burden of Rosacea and Encourages Healthcare Professionals to Look 'Beyond the visible'
Lausanne, Switzerland (ots/PRNewswire) - Galderma today released the findings of a global survey highlighting the need for dermatologists and doctors to proactively open a dialogue with patients about the true burden of rosacea and ways in which they can work together to achieve 'clear' (IGA 0) skin*. In the form of ...
plusThe US overtakes Hong Kong at first place among world's most competitive economies
plusFreenome and Biognosys announce collaboration to improve early-cancer detection and treatment
South San Francisco, California, USA and Schlieren, Switzerland (ots) - AI genomics company Freenome announces partnership with leading proteomics company Biognosys to enhance its broad-signal approach to early-cancer detection and precision oncology. By decoding cell-free (cf) biomarker patterns of once unthinkable ...
plusSequana Medical Announces Publication of Results of Multicentre Randomized Controlled Study
Zurich, SWITZERLAND (ots) - Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis Sequana Medical AG ("Sequana Medical"), a commercial stage medical device company and an innovator in the management of ...
plusTEND, the Experiential Investment Platform, Announces Token Sale That Will Spearhead New Token Sale Standards
Zug, Switzerland (ots/PRNewswire) - TEND selected by ETH Zurich Chair of Entrepreneurship to serve as research model for token sales TEND, the blockchain-powered experiential investment platform, announced in November 2017 by former Credit Suisse Chief Digital Officer, Marco Abele, today announced its upcoming Token ...
plusHombrechtikon Systems Engineering AG
HSE-AG introduces modular, automated qPCR TubeSealer / New bead-based technology integrates into any workflow and reduces contamination risk
plusAscensia Diabetes Care Celebrates Inspirational Women On World Diabetes Day 2017
Basel, Switzerland (ots/PRNewswire) - Today, Ascensia Diabetes Care, a leading diabetes care company, is showing its support for World Diabetes Day 2017 by publishing 30 portraits of inspiring women who are making significant contributions to advancing diabetes care. The theme of World Diabetes Day is Women and Diabetes, and through this initiative, Ascensia aims to ...
plusDebiopharm International SA Announces Dosing of First Patient in a Combination Trial of Debio 1143 and Avelumab in Patients with Solid Tumors Including Non-Small Cell Lung Cancer (NSCLC)
Lausanne, Switzerland (ots) - The clinical trial is in collaboration with the Merck-Pfizer Alliance Debiopharm International SA (Debiopharm - www.debiopharm.com), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company, today announced the dosing of the first patient in a Phase Ib study of Debio ...
plusSequana Medical Announces Publication of Results of alfapump® Multicentre, Post-Marketing Surveillance Registry in Alimentary Pharmacology & Therapeutics (AP&T)
Zurich, Switzerland (ots) - Sequana Medical AG (Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, announces the publication of "Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis", the results of the first ...
plusArbor Pharmaceuticals, LLC and Debiopharm International SA Announce Commercial Availability of Triptodur(TM), Triptorelin 6-month Formulation, for Treatment of Central Precocious Puberty (CPP)
Atlanta, GA, USA and Lausanne, Switzerland (ots) - Triptodur(TM), (triptorelin) extended release injectable suspension, has been shown to arrest or reverse the clinical signs of puberty associated with CPP via a once every six-month intramuscular (IM) injection. Arbor Pharmaceuticals, LLC, a U.S. based specialty ...
plusGalderma: 'Clear' (IGA 0) Rosacea Patients Experience a Delayed Time to Relapse
Lausanne, Switzerland (ots/PRNewswire) - Today, the results of a pooled analysis of four Galderma-sponsored studies evaluating the use of topical therapies for the treatment of inflammatory papules and pustules of rosacea were presented at the 26th European Academy of Dermatology and Venereology Congress in Geneva, Switzerland. The success of rosacea treatment is ...
plus- 2
Neovii Pharmaceuticals AG announces new CEO
plus Galderma: Combined Use of Rosacea Therapies Ivermectin 1% Cream and Brimonidine 0.33% Gel Evaluated in MOSAIC Study
Lausanne, Switzerland (ots/PRNewswire) - Today, the results of a study evaluating the combined use of topical rosacea treatments ivermectin 1% cream and brimonidine 0.33% gel were published in the Journal of Drugs in Dermatology. (Logo: http://mma.prnewswire.com/media/554005/Galderma_Logo.jpg ) "This is the first ...
plusEvalueserve expands its Board
Schaffhausen/Zurich, Switzerland (ots) - Professional services provider Evalueserve welcomes Dr. Christian Casal and Armin Meier to its Board of Directors to strengthen its leadership team. Dr. Christian Casal is a former Director of McKinsey & Co. Inc. and Armin Meier is the owner and Managing Director of Boyden global executive search AG. Both executives bring to the Board extensive senior management and corporate governance experience from private and public companies ...
plusMontreux Jazz Festival, Where Legends Inspire Young Talents
Paris and Montreux, Switzerland (ots/PRNewswire) - Clarendelle, exclusive foreign wine partner of the Montreux Jazz Festival Clarendelle joins the Montreux Jazz Festival by supporting the Montreux Jazz Artists Foundation in its mission to accompany the young talents of tomorrow. (Logo: http://mma.prnewswire.com/media/524397/Clarendelle_Logo.jpg ) (Logo: http://mma.prnewswire.com/media/529962/Montreux_Jazz_Arti ...
plusDebiopharm International SA and Arbor Pharmaceuticals, LLC Announce U.S. FDA Approval for Triptodur(TM), Triptorelin 6-month Formulation, in the Treatment of Central Precocious Puberty (CPP)
Lausanne, Switzerland and Atlanta, GA (ots) - Triptodur (TM), (triptorelin) for extended release injectable suspension, has been shown to arrest or reverse the clinical signs of puberty with once every six-month intramuscular injection (IM) dosing for children with CPP Approval brings new CPP treatment formulation ...
plusShire Pharmaceuticals Group Plc
Shire Announces EMA Validation of Veyvondi[TM] [Von Willebrand Factor (Recombinant)] Marketing Authorization Application for Treatment of Von Willebrand Disease
Zug, Switzerland (ots/PRNewswire) - VEYVONDI is the first and only recombinant von Willebrand factor treatment for adults with von Willebrand disease, the most common inherited bleeding disorder[1],[2],[3] Shire plc (LSE: SHP, NASDAQ: SHPG), the leading biotechnology company focused on serving individuals with rare ...
plusAlmac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor
Craigavon, N.I., UK, Lausanne, Switzerland (ots) - Almac Discovery (www.almacgroup.com/discovery), a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, and Debiopharm International SA (Debiopharm - www.debiopharm.com), a Switzerland based specialty ...
plus- 2
A new generation of anti-doping security bottles
plus Napapijri FW17 merges innovation and animal welfare / The new collection featuring the innovative Superlight Skidoo, is 100% down and fur free
plus- 11
Making a dream come true - despite hearing loss, a dancing star is born in China
plus GenePOC announces FDA clearance for revogene(TM) instrument and its GBS LB test
Québec, Canada and Lausanne, Switzerland (ots) - GenePOC announces it received 510(k) clearance from the US Food and Drug Administration to market its first molecular assay to detect Group B Streptococcus and for the revogene molecular diagnostics instrument. GenePOC, Inc. (GenePOC) a member of the Debiopharm Group is pleased to announce that it has received FDA ...
plusDebiopharm International SA Announces Results from Phase I Dose-Escalation Study of Debio 1347/CH5183284
Lausanne, Switzerland (ots) - Debio 1347/CH5183284 was evaluated in patients with FGFR genomically activated advanced solid tumors Debiopharm International SA (Debiopharm - www.debiopharm.com), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company, today announced the results from the phase I ...
plusDebiopharm International SA Enters the Field of Antibody-Drug Conjugates Through Acquisition of Phase II Asset from ImmunoGen
Lausanne, Switzerland and Waltham, Mass. (ots) - Transaction adds innovative clinical-stage program to expanding Debiopharm portfolio and broadens its clinical development expertise Divestiture aligns with ImmunoGen's focus on strategic growth initiatives and generates near-term value Debiopharm International SA ...
plusShire Pharmaceuticals Group Plc
Shire to Highlight New Research Into Chronic Hypoparathyroidism at the European Congress of Endocrinology
Zug, Switzerland (ots/PRNewswire) - New clinical and real-life data in chronic hypoparathyroidism, to advance understanding of this rare disease and improve patients' lives Shire plc (LSE: SHP, NASDAQ: SHPG), the global leader in rare diseases, announced today new research to be presented on rhPTH(1-84) and on the ...
plus